Rozltrek FDA Approved for Hard-to-Treat NTRK Fusion-Positive Tumors, Available at Biologics by McKesson

Vertex Pharmaceuticals files US FDA new drug application for VX-445 tezacaftor and ivacaftor triple combination regimen

Chrysalis BioTherapeutics wins FDA and EMA orphan drug status for TP508 for ARS

Bonesupport Holding extends patient enrolment schedule for ongoing FORTIFY study

Sobi to divest FDA Priority Review Voucher to AstraZeneca

Astellas Pharma and Pfizer submit sNDA for XTANDI for treating metastatic hormone-sensitive prostate cancer

Cassiopea submits NDA to US FDA for clascoterone cream 1% acne treatment

US FDA grants Moderna's mRNA-1893 fast track designation

HedgePath Pharmaceuticals updates change in name and ticker symbol

Richter unveils biosimilar teriparatide Terrosa across European osteoporosis market

The US FDA approves Xenleta (lefamulin) to treat community-acquired bacterial pneumonia

Boston Scientific wins US FDA approval of ImageReady MRI for Vercise Gevia Deep Brain Stimulation System for PD patients

US FDA agrees to PharmaMar's proposal to file for accelerated approval of New Drug Application for lurbinectedin in monotherapy

US FDA approves Celgene's Inrebic

European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis